Effectiveness of Case-Based Educational Scenarios in the Metaverse on Interpersonal Communication Skills, Academic Engagement, and Mind-Wandering in University Nursing Students

NCT07319819 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-01-06

No results posted yet for this study

Summary

This randomized controlled trial will evaluate the effect of case-based educational scenarios delivered in a metaverse environment on interpersonal communication skills, academic engagement, and mind-wandering among undergraduate nursing students. Fourth-level nursing students will be randomly assigned either to metaverse-based case scenarios integrated into their psychiatric nursing education or to usual teaching without metaverse exposure. Outcomes will be measured using validated scales for interpersonal communication, learning engagement, and mind-wandering before and after the intervention.

Conditions

  • Communication

Interventions

BEHAVIORAL

Metaverse Case-Based Educational Scenarios

The intervention consists of structured case-based scenarios delivered via an immersive metaverse platform, where students interact in real time with virtual patients and peers. Sessions will be designed to promote interpersonal communication, empathy, and academic engagement and to reduce mind-wandering during psychiatric nursing education activities. (You may later specify number of sessions, duration per session, and total intervention period when finalized.)

Sponsors & Collaborators

  • Port Said University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-25
Primary Completion
2026-03-01
Completion
2026-03-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07319819 on ClinicalTrials.gov